https://doi.org/10.55788/9e70ca66
ISOLATION (NCT04342312) is a 2-centre, prospective, observational study aimed at determining predictors of successful ablation in participants with AF [1]. An analysis presented by Dr Zarina Habibi (Maastricht University, the Netherlands) aimed at determining the predictive value of AF burden compared with the canonical classification (i.e. paroxysmal vs persistent) in terms of arrhythmia recurrence [2]. Participants were required to have 3 single-lead ECGs daily for 4 weeks prior to ablation. The AF burden value was determined using maximally selected rank statistics. The final analysis included 261 participants who had both the required ECG measurements and completed the 12-month follow-up.
A total of 65.1% of participants had paroxysmal AF and 34.9% of participants had persistent AF. The cut-off value of 42% burden was selected based on statistical calculations (<42% as low burden and >42% as high burden). As expected, participants with persistent AF had a higher probability of recurrent AF compared with participants with paroxysmal AF (P=0.015). Similarly, according to the 42% burden cut-off, participants with a high burden had more AF recurrence compared with participants with a low burden (P=0.006).
A further subanalysis by burden showed that participants with paroxysmal AF and high burden had fewer recurrences than participants with paroxysmal AF and low burden (P=0.012). However, for participants with persistent AF, the burden cut-off of 42% did not show a significant difference in arrhythmia recurrence.
“Our preliminary results suggest that pre-procedural AF burden is an important predictor of AF recurrences in patients undergoing ablation,” said Dr Habibi.
- Verhaert DVM, et al. Front Cardiovasc Med. 2022;9:879139.
- Habibi Z, et al. Preprocedural atrial fibrillation burden is associated with recurrence in patients undergoing atrial fibrillation ablation: findings from the ISOLATION AF Ablation Cohort Study. Atrial fibrillation: ablation 1. EHRA Congress 2024, 7–9 April, Berlin, Germany.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration Next Article
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation »
« ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration Next Article
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation »
Table of Contents: EHRA 2024
Featured articles
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Personalising Ablation Techniques
Ablate-by-LAW: CT-determined left atrial wall thickness for ablation titration in atrial fibrillation
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation
Style-AF: Improved outcomes with vascular closure versus figure-of-eight suture
Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy
ASTRO AF: No benefit of staged left atrial appendage isolation cryoballoon ablation over radiofrequency ablation
Innovative Ablation Strategies
Pulsed-field ablation vs high-power short-duration radiofrequency in paroxysmal AF
CryoCure-VT: Endocardial ultra-low temperature cryoablation effective in sustained monomorphic ventricular tachycardia
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
MRI head-to-head comparison of lesion quality following various ablation techniques
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation
Post-Ablation Recurrence
AF burden versus classical AF classification in predicting arrhythmia recurrence
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence
Factors associated with negative outcomes in post-operative atrial fibrillation
Arrhythmia Technologies
Smartphone rhythm monitoring optimises AF management following cardiac surgery
SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay
Premature battery depletion can affect a quarter of subcutaneous cardioverter defibrillators
New atrial fibrillation associated with a high risk of major cardiovascular outcomes
Related Articles
June 1, 2022
First results of the POWER FAST III trial
February 17, 2021
Active screening for AF improves clinical outcomes
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com